Literature DB >> 7023927

Role of cadmium in carcinogenesis with special reference to cancer of the prostate.

M Piscator.   

Abstract

It has been shown in animal experiments that injections of large amounts of cadmium cause sarcoma at injection sites or testicular damage and eventually testicular tumors. Long-term exposure with small doses of cadmium has not caused testicular or prostatic tumors in experimental animals. Epidemiological studies on cadmium-exposed workers have shown excess deaths due to prostatic cancer in at least three independent investigations. All reported cases probably had considerable exposure decades ago, but there are not enough data to permit any dose-response calculations. The general epidemiology of prostatic cancer was not taken into account in any of the studies. A review of recent literature on epidemiology of prostatic cancer has revealed some basic facts. Small latent prostatic cancer has been shown to be as common in areas with low mortality from prostatic cancer as in areas with high mortality. In the U.S. the black population has a much higher death rate from prostatic cancer than the white population. Marital status has also been implied as a factor in the development of prostatic cancer. Black populations in Africa have much lower death rates than blacks in the U.S., which may depend on large differences in dietary habits. Thus racial, sexual and nutritional factors might be important for the development of prostatic cancer, since they may influence hormonal status. Cadmium concentrations in testes and prostate increase during heavy exposure, and it has been shown that testosterone synthesis will decrease in cadmium-exposed animals. Excessive exposure may interfere with the zinc/hormone relationship in the prostate, which could be a possible explanation for the development of prostatic cancer in heavily exposed individuals. Direct action of cadmium on the cells is not likely, nor is it probable that low level exposure to cadmium can be a causative factor for prostatic cancer.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7023927      PMCID: PMC1568831          DOI: 10.1289/ehp.8140107

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  78 in total

1.  The prostatic carcinoma in laboratory animals: a bibliographic survey from 1900 to 1977.

Authors:  A Rivenson; J Silverman
Journal:  Invest Urol       Date:  1979-05

2.  CHROMIUM, CADMIUM AND LEAD IN RATS: EFFECTS ON LIFE SPAN, TUMORS AND TISSUE LEVELS.

Authors:  H A Schroeder; J J Balassa; W H Vinton
Journal:  J Nutr       Date:  1965-05       Impact factor: 4.798

3.  The presence of an inherent reproductive cycle in the male laboratory rat.

Authors:  S A GUNN; T C GOULD
Journal:  J Endocrinol       Date:  1958-11       Impact factor: 4.286

4.  The distribution of zinc within the human prostate.

Authors:  W K KERR; A G KERESTECI; H MAYOH
Journal:  Cancer       Date:  1960 May-Jun       Impact factor: 6.860

5.  Cancer mortality among cadmium production workers.

Authors:  R A Lemen; J S Lee; J K Wagoner; H P Blejer
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

6.  Zinc and magnesium in human prostate gland: normal, hyperplastic, and neoplastic.

Authors:  F Györkey; K W Min; J A Huff; P Györkey
Journal:  Cancer Res       Date:  1967-08       Impact factor: 12.701

7.  Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii.

Authors:  K Akazaki; G N Stemmerman
Journal:  J Natl Cancer Inst       Date:  1973-05       Impact factor: 13.506

8.  [Cadmiun and lung cancer].

Authors:  K Humperdinck
Journal:  Med Klin       Date:  1968-06-14

9.  Prostate cancer epidemiology: widowerhood and cancer in spouses.

Authors:  P Greenwald; V Kirmss; W S Burnett
Journal:  J Natl Cancer Inst       Date:  1979-05       Impact factor: 13.506

10.  Prostatic cancer: mortality and incidence rates by race and social class.

Authors:  V L Ernster; S Selvin; S T Sacks; D F Austin; S M Brown; W Winkelstein
Journal:  Am J Epidemiol       Date:  1978-04       Impact factor: 4.897

View more
  23 in total

1.  Incidence of cancer among workers producing calcium carbide.

Authors:  H Kjuus; A Andersen; S Langård
Journal:  Br J Ind Med       Date:  1986-04

2.  Carcinogenic effects of cadmium on the prostate of the rat.

Authors:  L Hoffmann; H P Putzke; H J Kampehl; R Russbült; P Gase; C Simonn; T Erdmann; C Huckstorf
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

3.  Protective effect of selenium on lung cancer in smelter workers.

Authors:  L Gerhardsson; D Brune; I G Nordberg; P O Wester
Journal:  Br J Ind Med       Date:  1985-09

4.  Oncogenicity of rat prostate cells transformed in vitro with cadmium chloride.

Authors:  L Terracio; M Nachtigal
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

5.  The distribution of cadmium within the human prostate.

Authors:  P M Lindegaard; S O Hansen; J E Christensen; B B Andersen; O Andersen
Journal:  Biol Trace Elem Res       Date:  1990-05       Impact factor: 3.738

6.  Zinc, cadmium and selenium concentrations in separated epithelium and stroma from prostatic tissues of different histology.

Authors:  A Feustel; R Wennrich; H Dittrich
Journal:  Urol Res       Date:  1987

7.  Occupational and community exposures to toxic metals: lead, cadmium, mercury and arsenic.

Authors:  P J Landrigan
Journal:  West J Med       Date:  1982-12

8.  Mortality of employees of the Atomic Weapons Establishment, 1951-82.

Authors:  V Beral; P Fraser; L Carpenter; M Booth; A Brown; G Rose
Journal:  BMJ       Date:  1988-09-24

9.  Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH).

Authors:  A Feustel; R Wennrich; D Steiniger; P Klauss
Journal:  Urol Res       Date:  1982

Review 10.  Nrf2 in liver toxicology.

Authors:  Keiko Taguchi; Thomas W Kensler
Journal:  Arch Pharm Res       Date:  2019-11-28       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.